Alnylam Pharmaceuticals
ALNY
ALNY
494 hedge funds and large institutions have $26.7B invested in Alnylam Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 118 funds opening new positions, 170 increasing their positions, 149 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
17.71% more ownership
Funds ownership: 93.86% → 111.57% (+18%)
14% more repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 149
11% more call options, than puts
Call options by funds: $298M | Put options by funds: $270M
Holders
494
Holding in Top 10
11
Calls
$298M
Puts
$270M
Top Buyers
| 1 | +$3.26B | |
| 2 | +$732M | |
| 3 | +$140M | |
| 4 |
Holocene Advisors
New York
|
+$129M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$114M |
Top Sellers
| 1 | -$656M | |
| 2 | -$275M | |
| 3 | -$150M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$120M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$90.8M |